Skip to main content

Leitlinien zur molekulargenetischen Diagnostik: Fragiles-X Syndrom und andere FMR1-assoziierte Syndrome

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Literatur

  1. 1.

    Biancalana V, Glaeser D, McQuaid S, Steinbach P (2015) EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet 23:417–425

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Claustres M, Kozich V, Dequeker E, Fowler B, Hehir-Kwa JY, Miller K, Oosterwijk C, Peterlin B, van Ravenswaaij-Arts C, Zimmermann U, Zuffardi O, Hastings RJ, Barton DE (2014) Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic). Eur J Hum Genet 22:160–170

    Article  PubMed  Google Scholar 

  3. 3.

    Fernandez-Carvajal I, Lopez Posadas B, Pan R, Raske C, Hagerman PJ, Tassone F (2009) Expansion of a FMR1 greyzone allele to a full mutation in two generations. J Mol Diagn 11:306–310

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Grigsby J, Bennett R, Brega A, Bounds L, Cogswell J, Greco C, Hagerman P, Hagerman R, Hall D, Jacquemont S, Leehey M, Paulich M, Rice C, Rubinstein D, Tassone F. Fragile X-associated tremor-ataxia syndrome (FXTAS): An X-linked neurodegenerative phenotype. American College of Medical Genetics Meeting; 2005.

  5. 5.

    Hagerman R, Hagerman P (2013) Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 12:786–798

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, Hagerman PJ (2007) Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord 22:203–206

    Article  PubMed  Google Scholar 

  7. 7.

    Murray A, Schoemaker MJ, Bennett CE, Ennis S, Macpherson JN, Jones M, Morris DH, Orr N, Ashworth A, Jacobs PA, Swerdlow AJ (2014) Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med 16:19–24

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Nolin SL, Brown WT, Glicksman A, Houck GE Jr, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F, Longshore J, Macpherson J, Mandel JL, Matthijs G, Rousseau F, Steinbach P, Vaisanen ML, von-Koskull H, Sherman SL (2003) Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72(2):454–464

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ (1996) A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 33:1022–1026

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leitlinien zur molekulargenetischen Diagnostik: Fragiles-X Syndrom und andere FMR1-assoziierte Syndrome. medgen 28, 466–472 (2016). https://doi.org/10.1007/s11825-016-0113-3

Download citation